Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;70(7):2225-2230.
doi: 10.4103/ijo.IJO_302_22.

Ophthalmic registries for rare eye diseases

Affiliations

Ophthalmic registries for rare eye diseases

Mohita Sharma et al. Indian J Ophthalmol. 2022 Jul.

Abstract

The prevalence of rare diseases has been estimated to be around 6%-8%, most of which are genetic in origin. Rare eye diseases constitute a critical public health concern. The major concerns for people suffering from these conditions are diagnosis, treatment, rehabilitation, limited resources, and health infrastructure. Also, as the number of people suffering from these disorders is less, it becomes difficult to study the epidemiological distribution and natural course of the disease. Thus, there is a need to establish registries for such rare disorders. This will help in creating a database of those suffering from rare eye diseases and will prove advantageous for both the patients and the researchers. For patients, it will be helpful as it will provide them will access to families suffering from similar problems, provide rehabilitation services, and provide access to clinical trials working on the development of new treatments for these rare disorders. From the researchers' point of view, it will be beneficial for them as they will then have access to a pool of data that can be used as a starting point of research on these rare disorders. At present, very few registries exist around the world and none in India. A systematic review of registries for rare eye diseases on Google and PubMed was done for existing registries, their methodology, services provided, applications, and advantages.

Keywords: Database; India; ophthalmic registries; rare eye diseases; research and clinical trials.

PubMed Disclaimer

Conflict of interest statement

None

Comment in

References

    1. Mateus HE, Pérez AM, Mesa ML, Escobar G, Gálvez JM, Montaño JI, et al. A first description of the Colombian national registry for rare diseases. BMC Res Notes. 2017;10:514. - PMC - PubMed
    1. Workshop on National Registries of RD. 2014. National Institute of Health. 2014. [Last accessed on 2022 Jan 30]. Available from:https://www.sciencedirect.com/topics/agricultural-and-biological-science... .
    1. Taruscio D, Vittozzi L, Choquet R, Heimdal K, Iskrov G, Kodra Y, et al. National registries of rare diseases in Europe:An overview of the current situation and experiences. Public Health Genomics. 2015;18:20–5. - PubMed
    1. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, et al. Creating a global rare disease patient registry linked to a rare diseases biorepository database:Rare Disease-HUB (RD-HUB) Contemp Clin Trials. 2010;31:394–404. - PMC - PubMed
    1. Mazzucato M, VisonàDalla Pozza L, Manea S, Minichiello C, Facchin P. A population-based registry as a source of health indicators for rare diseases:The ten-year experience of the Veneto Region's rare diseases registry. Orphanet J Rare Dis. 2014;9:37. - PMC - PubMed

Publication types